Health Care Professionals' Herpes Zoster Awareness and Vaccine Recommendations for Patients with COPD.

COPD educational Intervention herpes zoster preventive medicine vaccination

Journal

Chronic obstructive pulmonary diseases (Miami, Fla.)
ISSN: 2372-952X
Titre abrégé: Chronic Obstr Pulm Dis
Pays: United States
ID NLM: 101635411

Informations de publication

Date de publication:
26 Oct 2022
Historique:
pubmed: 7 10 2022
medline: 7 10 2022
entrez: 6 10 2022
Statut: ppublish

Résumé

The objective of this study was to assess health care professionals' (HCPs) knowledge of an increased herpes zoster (HZ) risk and burden for patients with chronic obstructive pulmonary disease (COPD), HCPs' familiarity with the Advisory Committee on Immunization Practices' (ACIP) HZ vaccine recommendations, and the HCPs' current adult vaccine practices. Another objective was to evaluate the impact of a short educational video on knowledge and future vaccine intent. An online survey of family physicians (FPs), pulmonologists, nurse practitioners (NPs), and physician assistants (PAs) querying demographics, awareness of ACIP HZ vaccine recommendations, and HZ burdens and risks in patients with COPD and their current recommendations for HZ, influenza, and pneumococcal vaccines was conducted. For those not strongly recommending HZ vaccines concordant with ACIP recommendations, a 5-minute educational video was presented, and post video questions assessed future intended HZ vaccine recommendations. Among 1020 HCP responders, awareness and ACIP concordant HZ vaccine recommendations ranged from 59.0% to 95.2% across HCPs. Lowest recommendation rates were consistently reported by pulmonologists for the 2-dose HZ vaccine beginning at age 50; for the 2-dose vaccine use in those with prior 1-dose HZ vaccinations, and for those with prior HZ. Among all HCPs, HZ vaccine recommendations were lower than for pneumococcal and influenza vaccines. After viewing the educational video, reported vaccine recommendation intent increased significantly in all groups of HCPs, as did awareness of increased HZ risk among patients with COPD. Significant educational opportunities exist for HCPs related to HZ and its vaccine prevention among patients with COPD which may be responsive to brief, targeted interventions.

Identifiants

pubmed: 36199223
doi: 10.15326/jcopdf.2022.0322
pmc: PMC9718579
doi:

Types de publication

Journal Article

Langues

eng

Pagination

562-575

Subventions

Organisme : GlaxoSmithKline Biologicals SA
Pays : United States

Informations de copyright

JCOPDF © 2022.

Références

PLoS One. 2014 Dec 09;9(12):e113503
pubmed: 25490542
MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103-108
pubmed: 29370152
J Patient Exp. 2020 Apr;7(2):169-180
pubmed: 32851137
Chronic Obstr Pulm Dis. 2021 Oct 28;8(4):474-487
pubmed: 34496465
SAGE Open Med. 2018 Sep 17;6:2050312118800209
pubmed: 30245819
Br J Gen Pract. 2019 Nov 28;69(689):596
pubmed: 31780472
Mayo Clin Proc. 2017 Dec;92(12):1806-1821
pubmed: 29202939
J Eval Clin Pract. 2015 Apr;21(2):339-46
pubmed: 25645368
JAMA Netw Open. 2020 Nov 2;3(11):e2024984
pubmed: 33151319
Vaccine. 2017 Jan 23;35(4):647-654
pubmed: 28024954
Vaccines (Basel). 2022 Mar 10;10(3):
pubmed: 35335052
Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119
pubmed: 27382600
MMWR Surveill Summ. 2021 May 14;70(3):1-26
pubmed: 33983910
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(3):80-84
pubmed: 35051134
Open Forum Infect Dis. 2020 Jan 09;7(1):ofaa005
pubmed: 32010734
CMAJ. 2011 Mar 22;183(5):E275-80
pubmed: 21343261
BMC Fam Pract. 2017 Dec 22;18(1):108
pubmed: 29272999
Pharm Pract (Granada). 2020 Jul-Sep;18(3):2160
pubmed: 33029264
J Am Board Fam Med. 2018 Jan-Feb;31(1):94-104
pubmed: 29330244
Pain. 2020 Feb;161(2):361-368
pubmed: 31599852
NCHS Data Brief. 2020 Jul;(370):1-8
pubmed: 32730737
Vaccine. 2018 Oct 29;36(45):6772-6781
pubmed: 30243501
Infect Dis Ther. 2019 Dec;8(4):687-694
pubmed: 31583578
Psychol Bull. 2006 Sep;132(5):778-822
pubmed: 16910754
J Infect Dis. 2018 Sep 22;218(suppl_2):S127-S133
pubmed: 30247592
BMC Infect Dis. 2018 May 3;18(1):203
pubmed: 29724175
BMC Fam Pract. 2020 Feb 29;21(1):46
pubmed: 32113475
Ann Intern Med. 2014 Feb 4;160(3):161
pubmed: 24658693
Cochrane Database Syst Rev. 2021 Jul 20;7:CD013706
pubmed: 34282603
Hum Vaccin Immunother. 2021 Jun 3;17(6):1714-1732
pubmed: 33651654
Hum Vaccin Immunother. 2019;15(3):637-642
pubmed: 30395771
Eye Contact Lens. 2014 Jul;40(4):225-31
pubmed: 24901974
J Gen Intern Med. 2019 Oct;34(10):2167-2175
pubmed: 31325130
Chronic Obstr Pulm Dis. 2021 Oct 28;8(4):502-516
pubmed: 34614552
Cornea. 2018 Aug;37(8):947-951
pubmed: 29578865
Vaccine. 2018 May 31;36(23):3351-3358
pubmed: 29716777
Vaccine. 2019 Sep 3;37(37):5509-5512
pubmed: 31400911
MMWR Morb Mortal Wkly Rep. 2021 Feb 19;70(7):245-249
pubmed: 33600384
Vaccine. 2015 Jun 4;33(24):2741-56
pubmed: 25936726
Infect Control Hosp Epidemiol. 2014 Jun;35(6):699-708
pubmed: 24799647
Hum Vaccin Immunother. 2020;16(1):70-75
pubmed: 31369322
JAMA. 2022 Feb 8;327(6):518
pubmed: 35133408

Auteurs

Barbara P Yawn (BP)

Department of Family and Community Health, University of Minnesota, Minneapolis, Minnesota, United States.
COPD Foundation, Miami, Florida, United States.

Natalia Y Loskutova (NY)

American Academy of Family Physicians National Research Network, Leawood, Kansas, United States.

Debora D Merrill (DD)

COPD Foundation, Miami, Florida, United States.

Sergio Martinez (S)

COPD Foundation, Miami, Florida, United States.

Elisabeth Callen (E)

American Academy of Family Physicians National Research Network, Leawood, Kansas, United States.

Janice Cotton (J)

COPD Foundation, Miami, Florida, United States.

Jennifer K Carroll (JK)

American Academy of Family Physicians National Research Network, Leawood, Kansas, United States.
Department of Family Medicine, University of Colorado, Aurora, Colorado, United States.

Dennis Williams (D)

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, North Carolina, United States.

Classifications MeSH